Data from Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells

MLA

Kapil N. Bhalla, et al. Data from Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........852ae1a9fc12f2161fed81c6ef04b0ac&authtype=sso&custid=ns315887.

APA

Kapil N. Bhalla, James E. Bradner, Swaminathan P. Iyer, Jianting Sheng, Ming Zhan, Santhana G.T. Devaraj, Melissa Rodriguez, Bryce P. Portier, Karissa Peth, Bhavin Shah, Leasha J. Schaub, John A. Valenta, Jun Qi, Sunil Sharma, & Warren Fiskus. (2023). Data from Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells.

Chicago

Kapil N. Bhalla, James E. Bradner, Swaminathan P. Iyer, Jianting Sheng, Ming Zhan, Santhana G.T. Devaraj, Melissa Rodriguez, et al. 2023. “Data from Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........852ae1a9fc12f2161fed81c6ef04b0ac&authtype=sso&custid=ns315887.